Synthetic Futures

The synthetic biology sector is starting to gain steam, as humankind gets closer to achieving its long-held ambitions to hack into the natural world and make it work for us, and more investors start to arrive on the scene, according to Entrepreneur.

Developments in recent years have made it more likely that companies can use synthetic biology tools to produce new products like materials, biofuels, flavors, drugs, and fragrances, among others, Britt Wray writes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.